Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HALO | ARWR | TECH | ||
| Company | Halozyme Therapeutic | Arrowhead Pharma | Bio-Techne Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 102.00 | 89.09 | 72.12 | ||
| High | 102.58 | 90.61 | 72.36 | ||
| Low | 100.47 | 87.16 | 72.10 | ||
| Last | 101.79 | 87.25 | 72.23 | ||
| Change | -0.83 | -1.99 | +0.08 | ||
| Percent Change | -0.81% | -2.23% | +0.11% | ||
| Volume | 3,650,500 | 1,119,600 | 2,359,000 | ||
| 20-Day Average Volume | 2,324,440 | 2,033,220 | 3,673,220 | ||
| Previous | 102.62 | 89.24 | 72.15 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 85.53 | 84.16 | 71.95 | ||
| 20-Day Raw Stochastic | 89.78% | 67.74% | 82.98% | ||
| 20-Day Relative Strength | 79.79 | 56.28 | 70.00 | ||
| Weighted Alpha | +60.59 | +207.76 | +35.81 | ||
| Today's Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Yesterday's Opinion | 100% Buy | 100% Buy | 88% Buy | ||
| Last Month's Opinion | 88% Buy | 56% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +21.77% since 08/05/26 | +0.39% since 08/05/26 | +0.32% since 08/05/26 | ||
| Low | 82.60 on 08/06/26 | 85.19 on 08/06/26 | 71.89 on 08/06/26 | ||
| High | 104.78 on 08/11/26 | 90.97 on 08/11/26 | 72.39 on 08/10/26 | ||
| 1-Month | |||||
| %Chg | +33.58% since 07/10/26 | +14.20% since 07/10/26 | +1.30% since 07/10/26 | ||
| Low | 73.89 on 07/15/26 | 69.88 on 07/15/26 | 71.10 on 07/13/26 | ||
| High | 104.78 on 08/11/26 | 95.49 on 07/22/26 | 72.39 on 08/10/26 | ||
| 3-Month | |||||
| %Chg | +43.51% since 05/12/26 | +10.39% since 05/12/26 | +52.32% since 05/12/26 | ||
| Low | 65.60 on 06/02/26 | 69.30 on 06/02/26 | 43.19 on 05/15/26 | ||
| High | 104.78 on 08/11/26 | 95.49 on 07/22/26 | 72.39 on 08/10/26 | ||
| 6-Month | |||||
| %Chg | +32.33% since 02/12/26 | +39.87% since 02/12/26 | +21.31% since 02/12/26 | ||
| Low | 61.33 on 03/27/26 | 54.02 on 03/13/26 | 43.19 on 05/15/26 | ||
| High | 104.78 on 08/11/26 | 95.49 on 07/22/26 | 72.39 on 08/10/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,552,961 | 12,289,772 | 11,308,980 | ||
| Shares Outstanding, K | 113,498 | 140,857 | 156,569 | ||
| Annual Sales, $M | 1,396,610,000 | 829,450,000 | 1,219,640,000 | ||
| Annual Net Income, $M | 316,890,000 | -1,630,000 | 73,400,000 | ||
| Last Qtr Sales, $M | 481,000,000 | 75,250,000 | 311,420,000 | ||
| Last Qtr Income, $M | 229,910,000 | -194,280,000 | 51,050,000 | ||
| 60-Month Beta | 0.85 | 1.27 | 1.28 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.28 on 08/06/26 | -1.36 on 08/04/26 | 0.52 on 08/12/26 | ||
| Latest Earnings Date | 11/02/26 | 11/24/26 | 08/12/26 | ||
| Most Recent Dividend | N/A | N/A | 0.080 on 05/18/26 | ||
| Next Ex-Dividend Date | N/A | N/A | 08/17/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 20.82 | 0.00 | 41.47 | ||